Liminatus Pharma, Inc. Class A Common Stock (LIMN) — Cash Flow Quality Index

Latest as of December 2021: -0.28x

Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Cash Flow Quality Index of -0.28x as of December 2021. Operating cash flow of $-1.22 Million is below net income of $4.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Liminatus Pharma, Inc. Class A Common St to assess how effectively this company generates cash.

Cash Flow Quality Index

-0.28x
Operating CF / Net Income

Operating Cash Flow

$-1.22 Million
USD

Net Income

$4.37 Million
USD

Data as of

Dec 2021
Most recent filing

Liminatus Pharma, Inc. Class A Common Stock Cash Flow Quality Index (2021–2021)

Historical Cash Flow Quality Index for Liminatus Pharma, Inc. Class A Common Stock across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Liminatus Pharma, Inc. Class A Common St (LIMN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Quality Index for Liminatus Pharma, Inc. Class A Common Stock (2021–2021)

Year-by-year earnings quality comparison for Liminatus Pharma, Inc. Class A Common Stock. For live market cap and the full company financial profile, see market value of Liminatus Pharma, Inc. Class A Common St.

Year Quality Index Operating CF (USD) Net Income YoY Change
2021 -0.28x $-1.22 Million $4.37 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.